These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7521612)

  • 1. Administration of drugs by infusion pumps in palliative medicine.
    Thorsen AB; Yung NS; Leung AC
    Ann Acad Med Singap; 1994 Mar; 23(2):209-11. PubMed ID: 7521612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Continuous drug infusion in terminal cancer].
    Ottesen S; Manger AT; Monrad L
    Tidsskr Nor Laegeforen; 1992 May; 112(14):1836-9. PubMed ID: 1378657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and causes for syringe driver site reactions in palliative care: A prospective hospice-based study.
    Mitchell K; Pickard J; Herbert A; Lightfoot J; Roberts D
    Palliat Med; 2012 Dec; 26(8):979-85. PubMed ID: 22084491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Continuous subcutaneous infusion in palliative care, an undervalued method].
    van Marum RJ; de Vogel EM; Zylicz Z
    Ned Tijdschr Geneeskd; 2002 Nov; 146(47):2221-4. PubMed ID: 12481516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of inoperable gastrointestinal obstruction in terminal cancer patients.
    Ventafridda V; Ripamonti C; Caraceni A; Spoldi E; Messina L; De Conno F
    Tumori; 1990 Aug; 76(4):389-93. PubMed ID: 1697993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliation of malignant intestinal obstruction using octreotide.
    Khoo D; Hall E; Motson R; Riley J; Denman K; Waxman J
    Eur J Cancer; 1994; 30A(1):28-30. PubMed ID: 7511400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of octreotide administration vs conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double- blind, controlled clinical trial.
    Mystakidou K; Tsilika E; Kalaidopoulou O; Chondros K; Georgaki S; Papadimitriou L
    Anticancer Res; 2002; 22(2B):1187-92. PubMed ID: 12168923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An introduction to the Micrel Micropump MP Daily portable syringe driver.
    Groves KE
    Int J Palliat Nurs; 2003 Nov; 9(11):468-73. PubMed ID: 14676723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous drug infusions: a review of problems and solutions.
    Mitten T
    Int J Palliat Nurs; 2001 Feb; 7(2):75-85. PubMed ID: 12271253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain.
    Moulin DE; Kreeft JH; Murray-Parsons N; Bouquillon AI
    Lancet; 1991 Feb; 337(8739):465-8. PubMed ID: 1704089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Until the chemist opens - palliation from the doctor's bag.
    Seidel R; Sanderson C; Mitchell G; Currow DC
    Aust Fam Physician; 2006 Apr; 35(4):225-31. PubMed ID: 16642239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of syringe drivers in palliative care.
    Gomez Y
    Aust Nurs J; 2000 Aug; 8(2):suppl 1-3. PubMed ID: 11894458
    [No Abstract]   [Full Text] [Related]  

  • 13. Palliative Care and the Management of Common Distressing Symptoms in Advanced Cancer: Pain, Breathlessness, Nausea and Vomiting, and Fatigue.
    Henson LA; Maddocks M; Evans C; Davidson M; Hicks S; Higginson IJ
    J Clin Oncol; 2020 Mar; 38(9):905-914. PubMed ID: 32023162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous subcutaneous infusion: flexible option in symptom control.
    Venning M; Rogers J
    Aust Nurses J; 1988 Feb; 17(7):34-7. PubMed ID: 3348762
    [No Abstract]   [Full Text] [Related]  

  • 15. Subcutaneous infusions for control of cancer symptoms.
    Storey P; Hill HH; St Louis RH; Tarver EE
    J Pain Symptom Manage; 1990 Feb; 5(1):33-41. PubMed ID: 1969887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of corticosteroids in palliative care.
    Shih A; Jackson KC
    J Pain Palliat Care Pharmacother; 2007; 21(4):69-76. PubMed ID: 18032321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous morphine infusion by syringe driver for terminally ill patients.
    Cools HJ; Berkhout AM; De Bock GH
    Age Ageing; 1996 May; 25(3):206-8. PubMed ID: 8670553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom control in advanced gastrointestinal cancer.
    Baines MJ
    Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):375-9. PubMed ID: 10783988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The benefits and drawbacks of syringe drivers in palliative care.
    Costello J; Nyatanga B; Mula C; Hull J
    Int J Palliat Nurs; 2008 Mar; 14(3):139-44. PubMed ID: 18414338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptom control in geriatric patients with terminal cancer: pain, nausea, and vomiting.
    Kinzel T
    Geriatrics; 1988 Jun; 43(6):83-4, 87-9. PubMed ID: 3366386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.